Choriogonadotropin alfa biosimilar - IVFarma
Latest Information Update: 16 Jan 2024
At a glance
- Originator iVFarma
- Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormone vaccines; Placental hormones; Recombinant proteins
- Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Female infertility
Most Recent Events
- 04 Dec 2023 Preclinical trials in Female infertility in Russia (Parenteral), prior to Novemeber 2023 (iVFarma pipeline, November 2023)